S1PR1 and hypersensitivity pneumonitis: Using the same murine HP model, we then showed that sphingosine-1-phosphate receptor 1 (S1P1)-targeting drugs strongly inhibited antigen-induced exacerbation and reduced the accumulation of both B cells and T cells in the airways [14].